by Lisa Willemse | Jun 29, 2012
With contributions from Michael Rudnicki. If you’re following recent announcements in the field, then you may know about the study published this week in Diabetes that details the use of human embryonic stem cells (hESCs) to reverse diabetes type 1 in a mouse...
by Angela C. H. McDonald | Jun 7, 2012
Late in May, the Brampton Fire Department (just outside of Toronto) held a “boot drive” to raise money for Muscular Dystrophy. My boyfriend who happens to be a firefighter tells me that boot drives are fairly common among Canadian fire departments. In fact, they are...
by Paul Krzyzanowski | May 22, 2012
Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where...
by Lisa Willemse | Feb 1, 2012
Some updates and news items of note: Call for boycott of subscriber-based journals gains momentum The ongoing friction between proponents of open access and the academic publishers has jumped into the spotlight once again with calls from a number of academics, most...
by Stem Cell Network | Jan 17, 2012
In recent years, the research community has been quite outspoken in its condemnation of rogue stem cell clinics operating in many countries across the globe. Indeed, through announcements made by health and related ministries in China, India and the US, it appears the...
by David Kent | Jan 12, 2012
Last fall, I wrote on the Eurostemcell documentary film entitled Stem Cell Revolutions: A Vision of the Future, which featured some experimental stem cell treatments in India, and since that time, I have tried to keep my finger on the pulse of what has been happening...
Comments